encorafenib,cetuximab,binimetinib
array biopharma,eli lilly,pfizer
['beacon']
the #oncoalerttoptweet day4 #esmo22 #eons15 tweet: subanalysis of beacon braf v600e mut in baseline ctdna in 91% of pts (higher tumor volume and levels of ctdna) reactivation of the mapk pathway the most common mechanism of resistance
best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??